Skip to main content
SpringerLink
Log in

ICER says evidence on anabolic agents for osteoporosis inadequate

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Institute for Clinical and Economic Review. Institute for Clinical and Economic Review's Final Evidence Report Finds Prices of Anabolic Agents for Osteoporosis Too High, Not Aligned with Potential Benefits Over Other Treatments. Internet Document : 17 Jul 2017. Available from: URL: https://icer-review.org/announcements/osteo-final-report/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ICER says evidence on anabolic agents for osteoporosis inadequate. PharmacoEcon Outcomes News 783, 4 (2017). https://doi.org/10.1007/s40274-017-4175-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4175-5

Search

Navigation